Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

bavarian nordic a/s - BVNRY

BVNRY

Close Chg Chg %
8.68 0.04 0.46%

Closed Market

8.72

+0.04 (0.46%)

Volume: 6.18K

Last Updated:

Dec 24, 2024, 12:59 PM EDT

Trade Now

Company Overview: bavarian nordic a/s - BVNRY

BVNRY Key Data

Open

$8.61

 Day Range

8.34 - 8.72

52 Week Range

6.86 - 14.60

 Market Cap

$2.06B

Shares Outstanding

235.95M

 Public Float

N/A

Beta

1.90

 Rev. Per Employee

N/A

P/E Ratio

12.47

 EPS

$0.70

Yield

0.00%

 Dividend

$0.54

EX-DIVIDEND DATE

Mar 27, 2020

 SHORT INTEREST

N/A

AVERAGE VOLUME

18.37K

  

BVNRY Performance

1 Week
 
 -2.68%
 
1 Month
 
 -5.01%
 
3 Months
 
 -24.83%
 
1 Year
 
 0.70%
 
5 Years
 
 N/A
 

BVNRY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About bavarian nordic a/s - BVNRY

Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.

BVNRY At a Glance

Bavarian Nordic A/S
Philip Heymans Alle 3
Hellerup, Capital Region 2900
Phone 45-33-26-83-83 Revenue 1.02B
Industry Pharmaceuticals: Major Net Income 214.05M
Sector Health Technology 2023 Sales Growth 130.051%
Fiscal Year-end 12 / 2024 Employees 1,379
View SEC Filings

BVNRY Valuation

P/E Current 12.47
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 9.424
Price to Sales Ratio 1.97
Price to Book Ratio 1.34
Price to Cash Flow Ratio 12.421
Enterprise Value to EBITDA 5.92
Enterprise Value to Sales 1.721
Total Debt to Enterprise Value 0.012

BVNRY Efficiency

Revenue/Employee 742,562.872
Income Per Employee 155,217.556
Receivables Turnover 3.689
Total Asset Turnover 0.524

BVNRY Liquidity

Current Ratio 1.938
Quick Ratio 1.348
Cash Ratio 0.67

BVNRY Profitability

Gross Margin 64.072
Operating Margin 21.219
Pretax Margin 21.013
Net Margin 20.903
Return on Assets 10.962
Return on Equity 16.733
Return on Total Capital 13.776
Return on Invested Capital 16.58

BVNRY Capital Structure

Total Debt to Total Equity 1.405
Total Debt to Total Capital 1.386
Total Debt to Total Assets 1.012
Long-Term Debt to Equity 0.955
Long-Term Debt to Total Capital 0.942
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Bavarian Nordic A/s - BVNRY

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
281.26M 300.51M 445.12M 1.02B
Sales Growth
+177.75% +6.84% +48.12% +130.05%
Cost of Goods Sold (COGS) incl D&A
185.29M 217.16M 211.37M 367.90M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
52.62M 61.62M 56.40M 80.36M
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
+224.93% +17.20% -2.67% +74.05%
Gross Income
95.97M 83.35M 233.74M 656.09M
Gross Income Growth
+116.94% -13.16% +180.45% +180.69%
Gross Profit Margin
+34.12% +27.73% +52.51% +64.07%
2020 2021 2022 2023 5-year trend
SG&A Expense
121.99M 134.20M 243.74M 438.81M
Research & Development
51.76M 62.69M 166.23M 320.44M
Other SG&A
70.23M 71.52M 77.51M 118.37M
SGA Growth
+33.28% +10.01% +81.62% +80.03%
Other Operating Expense
- - - -
-
Unusual Expense
22.33M 21.30M 36.27M 5.99M
EBIT after Unusual Expense
(48.34M) (72.15M) (46.27M) 211.30M
Non Operating Income/Expense
96.34M 2.87M 1.77M 6.05M
Non-Operating Interest Income
1.37M 2.03M 2.76M 7.92M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
4.87M 2.94M 2.35M 2.18M
Interest Expense Growth
+75.73% -39.68% -19.99% -7.25%
Gross Interest Expense
4.87M 2.94M 2.35M 2.18M
Interest Capitalized
- - - -
-
Pretax Income
43.12M (72.22M) (46.85M) 215.17M
Pretax Income Growth
+183.44% -267.49% +35.14% +559.30%
Pretax Margin
+15.33% -24.03% -10.52% +21.01%
Income Tax
681.27K 1.64M 2.23M 1.13M
Income Tax - Current - Domestic
681.27K 1.64M 2.23M 226.93K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - 898.15K
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
42.44M (73.87M) (49.07M) 214.05M
Minority Interest Expense
- - - -
-
Net Income
42.44M (73.87M) (49.07M) 214.05M
Net Income Growth
+181.64% -274.06% +33.56% +536.16%
Net Margin Growth
+15.09% -24.58% -11.03% +20.90%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
42.44M (73.87M) (49.07M) 214.05M
Preferred Dividends
- - - -
-
Net Income Available to Common
42.44M (73.87M) (49.07M) 214.05M
EPS (Basic)
0.2617 -0.3902 -0.2323 0.9301
EPS (Basic) Growth
+120.54% -249.10% +40.47% +500.39%
Basic Shares Outstanding
162.14M 189.31M 211.26M 230.13M
EPS (Diluted)
0.2617 -0.3902 -0.2323 0.9301
EPS (Diluted) Growth
+120.54% -249.10% +40.47% +500.39%
Diluted Shares Outstanding
162.14M 189.31M 211.26M 230.13M
EBITDA
26.60M 10.76M 46.40M 297.64M
EBITDA Growth
+168.67% -59.55% +331.31% +541.44%
EBITDA Margin
+9.46% +3.58% +10.42% +29.07%

Bavarian Nordic A/S in the News